ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Timber Pharmaceuticals Inc

Timber Pharmaceuticals Inc (TMBR)

0.3426
0.00
(0.00%)
마감 29 12월 6:00AM
0.00
0.00
(0.00%)
시간외 거래: -

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.3426
매수가
-
매도가
-
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
0.3426
개장가
-
최근 거래 시간
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

TMBR 최신 뉴스

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and...

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to be Acquired by LEO Pharma

Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to...

Timber Pharmaceuticals Discloses Communication From NYSE American

WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis

- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Absorption of Isotretinoin - - Data to be Presented at the Society for...

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled - WARREN, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber...

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results

- Timber has now Enrolled Over 60% of Patients for Pivotal TMB-001 Phase 3 ASCEND Clinical Trial - WARREN, NJ, May 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc...

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results

- Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital ichthyosis, ARCI and XLRI - - Timber has enrolled...

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

- Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the subtype of congenital ichthyosis - BASKING...

Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis

Company Progressing With Pivotal Phase 3 ASCEND Clinical Trial in the U.S., Canada, Italy, France, and Germany BASKING RIDGE, NJ, Feb. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TMBR - Frequently Asked Questions (FAQ)

What is the current Timber Pharmaceuticals share price?
The current share price of Timber Pharmaceuticals is US$ 0.3426
What is the 1 year trading range for Timber Pharmaceuticals share price?
Timber Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
GRFXGraphex Group Limited
US$ 0.435
(52.33%)
9.11M
WWRWestwater Resources Inc
US$ 0.85
(46.55%)
8.04M
RYDERyde Group Ltd
US$ 0.6298
(42.81%)
6.02M
AMBOAmbow Education Holding Ltd
US$ 3.09
(37.95%)
6.74M
BURUNuburu Inc
US$ 0.5857
(32.21%)
10.04M
USEUSCF Energy Commodity Strategy Absolute Return Fund
US$ 27.40
(-27.89%)
2.17k
ROLRHigh Roller Technologies Inc
US$ 4.02
(-21.02%)
53.43k
MMAMixed Martial Arts Group Limited
US$ 1.441
(-17.66%)
141.62k
CPHIChina Pharma Holdings Inc
US$ 0.176
(-15.79%)
2.51M
HTUSCapitol Series Trust
US$ 38.80
(-15.15%)
63.74k
UVIX2x Long VIX Futures ETF
US$ 3.215
(8.25%)
91.49M
OPTTOcean Power Technologies Inc
US$ 0.4711
(3.97%)
81.92M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.00
(3.27%)
81.61M
KULRKULR Technology Group Inc
US$ 4.66
(-2.92%)
77.49M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.195
(10.03%)
65.17M
Paulie Cashews Paulie Cashews 5 분 전
I almost stabbed myself in the face trying to lick melted cheese off a kitchen knife.

BTW, don't forget tonight on the Discovery Channel: "Cheese - Nature's Roadblock"

adserv.stocksite.com/images/paulie/tpubes1.jpg

www.investorshub.com/boards/plustrees.a
Scratchgolfer0 Scratchgolfer0 5 분 전
Absurd! Who inherits $20 million? Not anyone you know personally! Get real!
ALRTF
janice shell janice shell 5 분 전
One of the COVID Crackpots.
CYDY
delerious1 delerious1 5 분 전
He really shoud do his own DD....NBRI has been very forthcoming with the news every step of the way, IMO
NBRI
theorysuit theorysuit 6 분 전
1.81 to 4.92 with a normal retrace of 2.92. This stock still trades at under cash value. I have near to mid term fib targets of 6, 6.49, 6.87, 7.21, 7.58, 7.95, and 8.47 if you are looking for some exit points.
MGX
Konaploinks Konaploinks 7 분 전
With projected revenue growth of 100% annually, IonQ is expected to reach a target price of $126 in the near-term
IONQ
janice shell janice shell 8 분 전
Nope. Nothing I try works...
delerious1 delerious1 9 분 전
I wish....I tried putting in a stinkbid on Friday but the darn brokers at the Ask wouldn't budge....I tried dropping some names from here, but nope...my order never got filled
NBRI
WooptdooU WooptdooU 9 분 전
They may not need to prove FRAUD for SELF DEALING...check ot out...a real possibility.
LWLG
IceCold8 IceCold8 10 분 전
Maybe,he got what he deserved....Dignity Memorial
https://www.dignitymemorial.com › ...
Lawrence Garcia Obituary - Los Angeles, CA
AGSS
Jim Beem Jim Beem 10 분 전
.0004 ouch!
ASII
Ryoko Ryoko 11 분 전
If the audit and the "imminent" team deal had taken place, we would have heard something about it long ago. That said, there is no reason to believe that annual report will be audited. We go thru this lying BS every year. There's also no reason to believe 2025 will be any different as long as Matt A
IBGR
Monroe1 Monroe1 11 분 전
Can you post those links...again? Why are you foot draggin?
NBRI
AugustaFriends AugustaFriends 11 분 전
$VRPX which focuses on pain management. $VRPX has received grants from National Institutes of Health. The U.S. Army is studying the use of one of its drugs for battlefield wounds.

https://www.forbes.com/sites/lawrencelight/2024/01/14/virpax-a-promising-stock-in-a-sickly-biotech-mark
VRPX
Penny2Dime Penny2Dime 11 분 전
No dilution yet!
INCC
nagoya1 nagoya1 12 분 전
Huh? The numbers don’t work, there’s a share limit maximum. Do you suppose Bill Ak could’t afford to buy more than 10%….
Fnma
FNMA
DonVance DonVance 12 분 전
I predict new year day will see a major breakout.
BTCUSD
Monroe1 Monroe1 14 분 전
So that means when gold shows up, shorts will admit they are full of it, and hit the road?
Until then, give me more cheapies please.
NBRI
tat4tat tat4tat 14 분 전
My interpretation is that they refer to now being clocked at daily $63,000.00 for that particular day. Earlier they stated that they were at 48k so far for that same day at 1 O'Clock PST. Does this imlpy 63k every day? They word it in such a way as to imply 63k every day. Did I miss something. Prese
CEOS
Golden Cross Golden Cross 14 분 전
$ILLR Business Insider Covers Triller Hiring TikTok product head Sean Kim
https://www.youtube.com/watch?v=fevbIVpkB38

[yt]fevbIVpkB38[/yt]
ILLR
getmoreshares getmoreshares 14 분 전
CHUMP CHANGE- it fits!
CGAC
AugustaFriends AugustaFriends 14 분 전
$VRPX Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments.
VRPX
wadegarret wadegarret 15 분 전
GERN- I think it might have turned the corner Friday

when the stock sent from $3.20 to $3.35 on huge volume. I'm happy to now have about the same amount of shares in my real portfolio, that I had just before the ADCOM meeting in March.
GERN
Golden Cross Golden Cross 15 분 전
$ILLR ✨ Former Head of Product at TikTok Sean Kim joins Triller Group ~ Getting a high level executive that was with TikTok is Huge! 💫
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]
ILLR

최근 히스토리

Delayed Upgrade Clock